Hermetica Superfood Encyclopedia
The Short Answer
Meadow sage contains phenolic acids (including rosmarinic acid, ferulic acid, and chlorogenic acid), flavonoids, and essential oils dominated by thymol (~30%) and caryophyllene (~25–28%) that exert antioxidant activity via ROS scavenging, lipid peroxidation inhibition, and putative Nrf2 pathway activation. In vitro, one standardized S. pratensis extract (S3) demonstrated DPPH radical scavenging capacity with an IC50 comparable to ascorbic acid, and total phenolic content reaching approximately 400 mg GAE/100 g fresh weight, though no human clinical trial data currently exists to confirm these effects in vivo.
CategoryHerb
GroupEuropean
Evidence LevelPreliminary
Primary Keywordmeadow sage benefits
Meadow Sage — botanical close-up
Health Benefits
**Antioxidant Protection**
Phenolic acids including rosmarinic acid, ferulic acid, and chlorogenic acid scavenge reactive oxygen species (ROS) in vitro, with one extract achieving DPPH scavenging activity (IC50) comparable to ascorbic acid at approximately 10 µmol TE/g fresh weight.
**Anti-Inflammatory Potential**
Essential oil constituents including caryophyllene (~25–28%) and thymol (~30%) are associated with modulation of inflammatory signaling pathways observed in related Salvia species, suggesting potential inhibition of pro-inflammatory cytokine cascades.
**Antimicrobial Activity**: In vitro studies report activity of S
pratensis extracts against select bacterial strains, consistent with the broad antimicrobial properties of thymol-rich essential oils within the Lamiaceae family.
**Throat and Upper Respiratory Soothing**: In Eastern European folk medicine, S
pratensis has been employed as a throat remedy, likely attributable to the astringent and antimicrobial properties of its polyphenolic constituents and volatile oils.
**Lipid Peroxidation Inhibition**: Phenolics in S
pratensis extracts demonstrate inhibition of lipid peroxidation (LPO) in cell-free assay systems, mirroring rosmarinic acid's documented capacity to protect membrane lipids from oxidative degradation.
**Cytoprotective Support**
By analogy with closely related Salvia congeners, terpenoids and phenolics in meadow sage may support Nrf2 nuclear translocation, upregulating endogenous antioxidant enzymes such as heme oxygenase-1 (HO-1) and glutathione-S-transferase, though this has not been directly confirmed for S. pratensis.
**Potential Herbicidal and Allelopathic Activity**
Laboratory studies have examined S. pratensis extracts for herbicidal bioactivity, indicating the presence of phytochemicals with broad biological activity beyond conventional therapeutic applications.
Origin & History
Natural habitat
Salvia pratensis is native to central and southern Europe, growing across meadows, dry grasslands, roadsides, and calcareous soils from the British Isles eastward through the Balkans and into western Asia. It thrives in well-drained, alkaline-to-neutral soils under full sun at low to mid elevations, often colonizing disturbed habitats and traditional hay meadows. Unlike the commercially cultivated Salvia officinalis, meadow sage is predominantly collected from wild populations rather than systematically farmed, contributing to its understudied status in phytopharmacological literature.
“Salvia pratensis occupies a peripheral role in documented European ethnobotany compared to its congener S. officinalis, with meadow sage appearing in Eastern European folk medicine primarily as a throat remedy and general respiratory herb, though these uses are sparsely recorded in formal ethnopharmacological literature. The plant's common occurrence in central and southeastern European meadows suggests incidental use by rural communities who may have substituted it for the more potent garden sage when the latter was unavailable, a pattern consistent with the opportunistic use of wild Salvia species across Balkan and Carpathian folk traditions. No prominent historical medical texts—such as those of Dioscorides, Hildegard von Bingen, or the major Renaissance herbalists—specifically highlight S. pratensis as a distinct therapeutic species, reflecting either conflation with S. officinalis or genuine absence from formal medical discourse. Modern scientific literature characterizes it as 'neglected,' indicating that whatever traditional knowledge existed was not systematically codified or transmitted through academic or pharmaceutical channels.”Traditional Medicine
Scientific Research
The body of evidence for Salvia pratensis is limited exclusively to in vitro and phytochemical characterization studies; no clinical trials, randomized controlled studies, or systematic reviews specific to this species have been published as of current literature. Available laboratory studies document antioxidant capacity (DPPH, ABTS assays), total phenolic content quantification (~400 mg GAE/100 g FW), and antimicrobial screening against bacterial strains, representing the lowest tiers of preclinical evidence. Comparative phytochemical analyses situate S. pratensis within the broader Salvia genus alongside better-studied species such as S. officinalis and S. miltiorrhiza, from which mechanistic inference is drawn but cannot be directly extrapolated without species-specific data. The research community has explicitly described S. pratensis as a 'neglected' species, underscoring the significant gap between its observed in vitro bioactivity and any validated clinical application.
Preparation & Dosage
Traditional preparation
**Traditional Herbal Tea (Infusion)**
1–2 g of dried aerial parts per 200 mL boiling water, steeped 10–15 minutes; used in Eastern European folk practice for throat complaints, though no clinical dose has been validated
**Hydroalcoholic Extract (Methanol/Water)**
Used exclusively in laboratory research settings for phytochemical profiling; not a standardized commercial supplement form.
**Essential Oil (Hydrodistillation)**
Produced experimentally for antimicrobial and antioxidant assays; topical or aromatic use should follow general Salvia EO cautions due to thujone and thymol content; no therapeutic dose established.
**Standardized Extract**
No commercially standardized extract for S. pratensis currently exists; no standardization percentages (e.g., rosmarinic acid %) have been validated for this species.
**Timing/Duration**
No evidence-based guidance on timing or duration of use; general herbal tea preparation mirrors traditional S. officinalis practice of 2–3 cups daily for short-term throat symptom relief.
**Note**
All dosage considerations remain extrapolative; consultation with a qualified herbalist or physician is strongly advised before use.
Nutritional Profile
Meadow sage aerial parts contain modest macronutrient content typical of leafy herbaceous plants, with dietary fiber, trace proteins, and minimal lipids; precise macronutrient data for S. pratensis specifically is not reported in current literature. Total phenolic content (TPC) in research extracts reaches approximately 400 mg gallic acid equivalents (GAE) per 100 g fresh weight, with rosmarinic acid identified as a primary contributor in the most active extract fractions (S3). Flavonoids including luteolin and apigenin glycosides are presumed present based on genus-level characterization, though species-specific quantification is lacking. Essential oil composition is the most precisely characterized fraction: thymol (~30%), β-caryophyllene (~25–28%), and p-cymene (~9%) dominate, with minor contributions from α-pinene and other monoterpenoids. Phenolic acids identified include ferulic acid, chlorogenic acid, and p-coumaric acid; bioavailability of these polyphenols is expected to be moderate and matrix-dependent, with glycoside forms requiring intestinal hydrolysis prior to absorption, consistent with patterns observed across Salvia species.
How It Works
Mechanism of Action
The primary antioxidant mechanism of Salvia pratensis is attributed to hydrogen atom transfer (HAT) and single electron transfer (SET) by rosmarinic acid, ferulic acid, and chlorogenic acid, which directly neutralize DPPH•, hydroxyl, and superoxide radicals in vitro. Essential oil constituents thymol and caryophyllene are known in related species to modulate nuclear factor erythroid 2-related factor 2 (Nrf2) signaling, promoting nuclear translocation and upregulation of phase II detoxification enzymes including glutathione peroxidase and superoxide dismutase. Caryophyllene, a bicyclic sesquiterpene abundant in the S. pratensis essential oil (~25–28%), acts as a selective agonist of the cannabinoid type-2 receptor (CB2R) in related plant species, potentially dampening NF-κB-mediated inflammatory gene expression, though this interaction has not been directly demonstrated for S. pratensis isolates. Collectively, these phytochemicals may also inhibit the arachidonic acid cascade and cyclooxygenase (COX) enzyme activity by analogy with structurally related Salvia phenolics, contributing to the plant's putative anti-inflammatory profile.
Clinical Evidence
No clinical trials have been conducted evaluating Salvia pratensis as a medicinal or nutritional intervention in human subjects, and therefore no effect sizes, confidence intervals, or validated therapeutic outcomes can be reported. The entirety of available evidence consists of in vitro assays and phytochemical profiling, which establish bioactive compound presence and preliminary biological activity but do not constitute evidence of human efficacy or safety. Extrapolation from clinical studies on Salvia officinalis—which has demonstrated modest evidence for cognitive function, menopausal symptoms, and antimicrobial effects in small human trials—provides contextual framing but cannot substitute for species-specific data. Confidence in any therapeutic application of S. pratensis remains very low pending preclinical animal studies and subsequent human trials.
Safety & Interactions
Formal safety data for medicinal use of Salvia pratensis in humans is absent; no toxicology studies, adverse event reports, or maximum tolerated dose data have been published for this species specifically. General precautions applicable to thujone-containing Salvia essential oils are relevant: thujone is a monoterpene ketone with dose-dependent neurotoxic potential (convulsant at high doses), though thujone content in S. pratensis essential oil has not been quantified and may differ substantially from S. officinalis. Individuals taking anticonvulsant medications, CNS depressants, or antidiabetic agents should exercise caution given the pharmacological activity of Salvia genus essential oils and phenolics in analogous species, which have shown hypoglycemic and CNS-modulating effects in preclinical models. Pregnancy and lactation contraindications cannot be formally assessed due to absent safety data; by precautionary principle and analogy with S. officinalis—which is contraindicated in pregnancy due to uterotonic and thujone concerns—S. pratensis should be avoided during pregnancy and breastfeeding until safety is established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Salvia pratensisMeadow ClaryField SagePrairie Sage (colloquial)Wiesen-Salbei (German)
Frequently Asked Questions
What is meadow sage (Salvia pratensis) used for medicinally?
Meadow sage has been used in Eastern European folk medicine primarily as a throat remedy, likely due to the astringent and antimicrobial properties of its thymol-rich essential oil and polyphenolic constituents including rosmarinic acid and chlorogenic acid. However, these traditional uses are poorly documented in scientific literature, and no clinical trials have validated any specific medicinal application for S. pratensis in humans.
Is meadow sage the same as garden sage (Salvia officinalis)?
No, meadow sage (Salvia pratensis) and garden sage (Salvia officinalis) are distinct species within the Salvia genus, differing in habitat, phytochemical profile, and level of scientific study. Garden sage is extensively researched with documented cognitive, antimicrobial, and menopausal benefits, whereas meadow sage is described in current literature as a 'neglected' species with only preliminary in vitro data and no validated therapeutic applications.
Does meadow sage contain thujone, and is it safe?
Thujone, a potentially neurotoxic monoterpene ketone present in Salvia officinalis, is a concern for the Salvia genus broadly, but its specific concentration in S. pratensis essential oil has not been quantified in published research. Without safety data, meadow sage should be used with caution, particularly by individuals with seizure disorders, pregnant or breastfeeding women, and those taking medications affecting the central nervous system or blood glucose.
What are the main bioactive compounds in meadow sage?
The primary bioactive compounds identified in Salvia pratensis include phenolic acids (rosmarinic acid, ferulic acid, chlorogenic acid, p-coumaric acid), flavonoids, and essential oil constituents dominated by thymol (~30%), β-caryophyllene (~25–28%), and p-cymene (~9%). Total phenolic content in research extracts reaches approximately 400 mg GAE per 100 g fresh weight, with the most active extract fraction showing DPPH radical scavenging comparable to ascorbic acid in vitro.
What is the recommended dose of meadow sage supplement?
No clinically validated or standardized supplemental dose exists for Salvia pratensis, as no human clinical trials have been conducted with this species. Traditional herbal practice in Eastern Europe parallels preparation methods used for related sage species, suggesting 1–2 g of dried aerial parts as a tea infusion per serving, but this is empirical and not supported by pharmacokinetic or safety data; a qualified herbalist or physician should be consulted before use.
Does meadow sage have anti-inflammatory effects, and what compounds are responsible?
Yes, meadow sage's essential oil contains significant anti-inflammatory constituents, particularly caryophyllene (25–28%) and thymol (~30%), which are known to modulate inflammatory pathways. These volatile compounds work through multiple mechanisms to reduce inflammatory markers, making meadow sage potentially beneficial for conditions involving systemic inflammation. The anti-inflammatory activity is supported by traditional use and emerging pharmacological evidence.
How does meadow sage compare to other sage species for antioxidant protection?
Meadow sage contains robust antioxidant compounds including rosmarinic acid, ferulic acid, and chlorogenic acid that demonstrate DPPH scavenging activity comparable to ascorbic acid (vitamin C) at approximately 10 µmol TE/g fresh weight. While garden sage (Salvia officinalis) also contains these phenolic acids, meadow sage extracts show competitive antioxidant potency in vitro, making it equally relevant for oxidative stress protection. The antioxidant profile of meadow sage makes it a viable alternative to other sage species for free radical scavenging.
Can meadow sage be used as a natural antioxidant source, and how does it compare to synthetic alternatives?
Meadow sage's phenolic acid content provides measurable antioxidant capacity that rivals synthetic benchmarks like ascorbic acid in laboratory testing, offering a plant-based option for addressing oxidative stress. However, bioavailability of these compounds in the human body may differ from synthetic antioxidants, and most evidence currently exists at the in vitro level rather than from human clinical studies. Meadow sage may serve as a complementary dietary source of antioxidants, though more clinical research is needed to establish equivalent efficacy in vivo.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w meadow-sage-salvia-pratensis curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
